Quintara Biosciences

Why Sequence RBD

Emerging SARS-CoV-2 Variants have mutations in the receptor binding domain (RBD) of the spike protein, including K417N, E484K, N501Y. Some variants seem to spread more easily and quickly among people, causing more infections with the COVID-19 virus.

Spike Protein

Spike proteins is a glycoprotein on the surface of SAR virus, it could bind to receptor on host cells, and the allow virus to enter host cells.

RBD

Receptor Binding Domain (RBD) is part of spike protein (amino acid 330-535), it binds to the host receptor via a receptor-binding motif.

Vaccine

SARS-CoV-2 nAbs bind to RBD and block the RBD–hACE2 interaction, thus inhibiting virus attachment.



MA Site

boston@quintarabio.com
1-617-943-2768
625 Mt Auburn St, Suite 105
Cambridge, MA 02138

CA Site

quintara2011@quintarabio.com
1-510-910-2168
3583 Investment Blvd, Suite 2
Hayward, CA 94545

CT Site

ct@quintarabio.com
1-617-480-9886
400 Farmington Ave, Suite 1702
Farmington, CT 06032

MD Site

dc@quintarabio.com
1-301-761-4835
5350 Partners Ct, Suite C
Frederick, MD 21703